Dalphene Labs
Regulation, scope of practice, and the rulings that protect the clinic.
Compliance, page 3
1234See more →
Compliance
FDA Committee Recommends Adding Six Peptides to Compounding List
FDA Panel Recommends Adding Six Peptides to 503A Compounding List
Compliance
FDA committee scheduled to review compounder access for seven peptide substances
FDA Advisory Committee Prepares to Review Compounder Access for BPC-157, TB-500, and Key Peptides
Compliance
FDA committee to review compounding eligibility for seven peptides in July
FDA's July 2026 PCAC Meeting Scheduled to Review Peptide Compounding Eligibility
Compliance
South Korea tightens medical device quality and distribution rules for 2026
South Korea's Amended Medical Device Act Tightens QMS and Distribution Rules
Compliance
Rhode Island passes law requiring med spas to license as healthcare facilities
Rhode Island Medical Spas Safety Act Healthcare Licensure Rules Take Effect
Compliance
AbbVie and Allergan sue Galderma over redesigned Restylane syringe shape
AbbVie and Allergan Sue Galderma Over Redesigned Restylane Syringe Design
Compliance
South Korea Moves to Allow In Vitro Sunscreen Testing
South Korea Ministry of Food and Drug Safety Proposes In Vitro Sunscreen Testing Rules
Compliance
Saudi Arabia bans syringe-style packaging for topical cosmetics
Saudi Arabia Bans Syringe-Style Cosmetic Packaging to Eliminate Injection Confusion
Compliance
Peptide Council launches to establish compounding standards
New Peptide Council Launches to Establish Compounding Standards
Compliance
Ohio House Bill 377 eases laser hair removal delegation rules
Ohio House Bill 377 Rewrites Laser Delegation and Supervision Standards
Compliance
South Korea bans misleading AI virtual personas in cosmetic advertising
South Korea Bans Misleading AI-Generated Endorsements in Cosmetic Advertising
Compliance
FDA issues complete response letter to Galderma for RelabotulinumtoxinA
Galderma Progresses FDA Regulatory Review for RelabotulinumtoxinA